Medicare bankrupt in 2017, two years ahead of forecast

13 May 2009

The US Medicare program will run out of money by 2017, according to the latest assessment of its trustees, two years earlier than previously  imagined. Reduced revenues and increased demand for the scheme, which  provides health care to elderly people, mean that Medicare and the  Social Security fund, which provides the state pension, are both running  greater deficits than expected.

The news prompted calls by Democrats for accelerated health care reform,  which supporters claim will reduce government spending as the US  population becomes healthier and becomes less reliant on expensive  emergency care (Marketletters passim).

Tim Geithner, the Treasury Secretary, said: "the longer we wait to  address the longer-term solvency of Medicare and Social Security the  sooner those challenges will be upon us and the harder the options will  be."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight